Not Yet RecruitingNot Applicable

In Search of the Correct Diagnosis of Beta-lactam Allergy: From the Validation of a Risk Stratification Tool to Accurate Endotyping

332 participantsStarted 2025-07

Plain-language summary

Testing a clinical decision tool (BL-Predictor)

Age range14 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * signed informed consnet Exclusion Criteria: * Use of immunomodulators, antihistamines and corticosteroids

The main goal of this project is to test a cliniacl decision toll to stratify BL allergic pataients in low and mediaum- anf high-risk

Timeframe: April 2029- june 2027

NCT IDNCT07011212

SponsorFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-07

Marina Labella Alvarez MLB Bonilla Toyos